Recovery of kidney function · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vascular access complications · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vascular access complications · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Circuit lifespana · AKI patients receiving CKRT
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether CVVHDF changes death from any cause at day 28 of compared with CVVH (very low certainty).
1 finding from 1 review
Recovery of kidney function · AKI patients receiving CKRT
It is very uncertain whether CVVHDF changes recovery of kidney function compared with CVVH (very low certainty).
1 finding from 1 review
Vascular access complications · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Circuit lifespana · AKI patients receiving CKRT
1 finding from 1 review
Change in weight (kg) · adults with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes change in weight (kg) compared with NECT plus cimetidine (very low certainty).
1 finding from 1 review
Change in BMI · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain frequency or change in frequency · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes frequency of bowel symptoms: abdominal pain (% of days affected) compared with ECT (very low certainty).
1 finding from 1 review
CFA: change in FFE (g/day) · adults and children with cystic fibrosis
Summary of findings: ECM showed no clear difference in CFA: change in FFE (g/day) compared with ECT (low certainty).
1 finding from 1 review
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · children with cystic fibrosis and proven pancreatic insufficiency
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in height · children with cystic fibrosis and proven pancreatic insufficiency
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in BMI · children with cystic fibrosis and proven pancreatic insufficiency
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of bowel symptoms · children with cystic fibrosis and proven pancreatic insufficiency
1 finding from 1 review
CFA: change in FFE (g/day) · children with cystic fibrosis and proven pancreatic insufficiency
It is very uncertain whether summary of findings: ECM changes CFA: change in FFE (g/day) compared with ECMM (very low certainty).
1 finding from 1 review
Change in height · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found